Maureen M. Hester

发表

Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.

P. Khoshkenar, G. Ostroff, C. Specht, 2019, Vaccine.

Cross-reactivity between vaccine antigens from the chitin deacetylase protein family improves survival in a mouse model of cryptococcosis

G. Ostroff, C. Specht, D. Lourenço, 2022, Frontiers in Immunology.

LUNG EOSINOPHIL ALTERATIONS IN A CRYPTOCOCCUS NEOFORMANS MURINE INFECTION MODEL

Maureen M. Hester, 2016 .

Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles

F. Rus, G. Ostroff, C. Specht, 2021, bioRxiv.

Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species

J. Lodge, P. Khoshkenar, G. Ostroff, 2017, mBio.

Immunological correlates of protection following vaccination with glucan particles containing Cryptococcus neoformans chitin deacetylases

G. Ostroff, C. Specht, D. Lourenço, 2023, npj Vaccines.

Protection of mice against experimental cryptococcosis by Protection of mice against experimental cryptococcosis by synthesized peptides delivered in glucan particles [preprint] synthesized peptides delivered in glucan particles [preprint] how this benefits you.

F. Rus, G. Ostroff, Chrono K. Lee, 2022 .

Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines

S. Levitz, Maureen M. Hester, Ruiying Wang, 2024, bioRxiv.